Blog
-
-
UMass, CommonSpirit among collection of health systems to form new specialty pharmacy alliance
-
Treatment Reverses Young Man’s Type 1 Diabetes. Will It Last?
-
5 FDA approval decisions to watch in the 4th quarter
-
Novartis’ Zolgensma expansion hits FDA roadblock, giving Biogen and Roche a reprieve
-
CMS approves chronic kidney disease payment model
-
Here’s how much faster drug prices are rising compared to other healthcare services
-
FDA approves Medtronic’s Bluetooth-controlled insulin pump for children ages 2 and up
-
Medicare proposes coverage of ‘breakthough’ medical devices
-
Sarepta, after two dramatic approvals, gets an FDA review for next Duchenne drug